Addressing Unmet Needs in Vaccination for Older Adults in the Asia Pacific: Insights from the COVID-19 Pandemic

References

• Privor-Dumm LA, Poland GA, Barratt J, et al. A global agenda for older adult immunization in the COVID-19 era: a roadmap for action. Vaccine. 2021;39(37):5240–5250. doi:10.1016/j.vaccine.2020.06.082
   PubMed Web of Science ®Google Scholar
• Wagner A, Weinberger B. Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives. Front Immunol. 2020;11:717.
   PubMed Web of Science ®Google Scholar
• Sachet G, Hardesty C, Aizan T, et al. The decade of healthy ageing in ASEAN: role of life-course immunisation; 2021. Available from: https://www.eu-asean.eu/wp-content/uploads/2022/02/The-Decade-of-Healthy-Ageing-in-ASEAN-Role-of-Life-course-Immunisation-2021.pdf. Accessed October 20, 2022.
   Google Scholar
• Litt J, Booy R, Bourke D, et al. Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine. Hum Vaccin Immunother. 2020;16(12):3081–3089. doi:10.1080/21645515.2020.1754702
   PubMed Web of Science ®Google Scholar
• Seth A, Pangestu T. Promoting older adults immunization: a pathway to healthy aging in the Asia Pacific; 2021. Available from: https://medicine.nus.edu.sg/apic/wp-content/uploads/sites/28/2022/06/APIC_Policy_Brief_Life_Course_Immunisation_Final_June-2022-1.pdf. Accessed October 20, 2022.
   Google Scholar
• Jiang X, Shang X, Lin J, Zhao Y, Wang W, Qiu Y. Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: a quasi-experimental study. Vaccine. 2021;39(5):846–852. doi:10.1016/j.vaccine.2020.12.040
   PubMed Web of Science ®Google Scholar
• Bai X, Chen L, Liu X, et al. Adult hepatitis B virus vaccination coverage in China from 2011 to 2021: a systematic review. Vaccines. 2022;10(6). doi:10.3390/vaccines10060900
   Web of Science ®Google Scholar
• Verma R, Khanna P, Chawla S. Vaccines for the elderly need to be introduced into the immunization program in India. Hum Vaccin Immunother. 2014;10(8):2468–2470. doi:10.4161/hv.29254
   PubMed Web of Science ®Google Scholar
• Vora A, Di Pasquale A, Kolhapure S, Agrawal A. Vaccination in older adults: an underutilized opportunity to promote healthy aging in India. Drugs Aging. 2021;38(6):469–479. doi:10.1007/s40266-021-00864-4
   PubMed Web of Science ®Google Scholar
• Cowling BJ, Caini S, Chotpitayasunondh T, et al. Influenza in the Asia-Pacific region: findings and recommendations from the Global Influenza Initiative. Vaccine. 2017;35(6):856–864. doi:10.1016/j.vaccine.2016.12.064
   PubMed Web of Science ®Google Scholar
• Owusu JT, Prapasiri P, Ditsungnoen D, et al. Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010–2012. Vaccine. 2015;33(5):742–747. doi:10.1016/j.vaccine.2014.10.029
   PubMed Web of Science ®Google Scholar
• Menzies R, Stein AN, Booy R, Van Buynder PG, Litt J, Cripps AW. The impact of the changing pneumococcal national immunisation program among older Australians. Vaccine. 2021;39(4):720–728. doi:10.1016/j.vaccine.2020.12.025
   PubMed Web of Science ®Google Scholar
• Chen Q, Wang L, Xie M, Li X; Recommendations for Influenza SpViEPiCWGGRG, Chinese Society of G. Recommendations for influenza and Streptococcus pneumoniae vaccination in elderly people in China. Aging Med. 2020;3(1):4–14. doi:10.1002/agm2.12102
   Google Scholar
• Hou Z, Guo J, Lai X, et al. Influenza vaccination hesitancy and its determinants among elderly in China: a national cross-sectional study. Vaccine. 2022;40(33):4806–4815. doi:10.1016/j.vaccine.2022.06.063
   PubMed Web of Science ®Google Scholar
• Krishnan A, Dar L, Amarchand R, et al. Cohort profile: Indian Network of Population-based surveillance platforms for Influenza and Other Respiratory Viruses among the Elderly (INSPIRE). BMJ Open. 2021;11(10):e052473. doi:10.1136/bmjopen-2021-052473
   PubMed Web of Science ®Google Scholar
• Dash R, Agrawal A, Nagvekar V, et al. Towards adult vaccination in India: a narrative literature review. Hum Vaccin Immunother. 2020;16(4):991–1001. doi:10.1080/21645515.2019.1682842
   PubMed Web of Science ®Google Scholar
• Zahra. The availability of vaccines in Indonesia is adequate, but the availability of cold chain infrastructure facilities is still experiencing obstacles; 2021. Available from: https://feb.ugm.ac.id/en/news/3494-The-availability-of-vaccines-in-indonesia-is-adequate-but-The-availability-of-cold-chain-infrastructure-facilities-is-still-experiencing-obstacles. Accessed October 20, 2022.
   Google Scholar
• Utami A, Margawati A, Pramono D, Nugraheni A, Pramudo SG. Determinant factors of COVID-19 vaccine hesitancy among adult and elderly population in Central Java, Indonesia. Patient Prefer Adherence. 2022;16:1559–1570. doi:10.2147/PPA.S365663
   PubMed Web of Science ®Google Scholar
• Vaccinations; 2021. Available from: http://japanhpn.org/en/vaccinations-2/. Accessed October 20, 2022.
   Google Scholar
• Wong LP, Wong PF, AbuBakar S. Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country. Hum Vaccin Immunother. 2020;16(7):1511–1520. doi:10.1080/21645515.2019.1706935
   PubMed Web of Science ®Google Scholar
• Cruz GT, Laguna EP, Paguirigan MRB, et al. Vaccinating the most vulnerable group in the time of pandemic: insights from a national survey of older people (UPPI/DRDF Research Brief No. 9); 2021. Available from: https://www.uppi.upd.edu.ph/research/covid-19/rb9. Accessed October 20, 2022.
   Google Scholar
• Amit AML, Pepito VCF, Sumpaico-Tanchanco L, Dayrit MM. COVID-19 vaccine brand hesitancy and other challenges to vaccination in the Philippines. PLOS Glob Public Health. 2022;2(1):e0000165. doi:10.1371/journal.pgph.0000165
   PubMedGoogle Scholar
• Nguyen MH, Li Chen L, Lim KW, Chang WT, Mamun K. Vaccination in older adults in Singapore: a summary of recent literature. Proceed Singapore Healthc. 2015;24(2):94–102. doi:10.1177/201010581502400205
   Google Scholar
• Yang TU, Kim E, Park Y-J, et al. Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure. Vaccine. 2016;34(13):1623–1629. doi:10.1016/j.vaccine.2016.01.043
   PubMed Web of Science ®Google Scholar
• Chen CH, Wu MS, Wu IC. Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan: a nation-wide community-based study. Medicine. 2018;97(5):e9773. doi:10.1097/MD.0000000000009773
   PubMed Web of Science ®Google Scholar
• Nicholls LAB, Gallant AJ, Cogan N, Rasmussen S, Young D, Williams L. Older adults’ vaccine hesitancy: psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake. Vaccine. 2021;39(26):3520–3527. doi:10.1016/j.vaccine.2021.04.062
   PubMed Web of Science ®Google Scholar
• Govaert TME, Thijs CT, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA. 1994;272(21):1661–1665. doi:10.1001/jama.1994.03520210045030
   PubMed Web of Science ®Google Scholar
• Raina MacIntyre C, Menzies R, Kpozehouen E, et al. Equity in disease prevention: vaccines for the older adults – a national workshop, Australia 2014. Vaccine. 2016;34(46):5463–5469. doi:10.1016/j.vaccine.2016.09.039
   PubMed Web of Science ®Google Scholar
• Woodward M. Immunisation of older people. J Pharm Pract Res. 2012;42(4):316–322. doi:10.1002/j.2055-2335.2012.tb00197.x
   Google Scholar
• Dhama K, Sharun K, Tiwari R, et al. COVID-19 vaccine hesitancy – reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum Vaccin Immunother. 2021;17(10):3495–3499. doi:10.1080/21645515.2021.1926183
   PubMed Web of Science ®Google Scholar
• Hosoda M. Vaccine hesitancy in Japan: from a perspective on medical uncertainty and trans-scientific theory [version 2; peer review: 2 approved, 1 approved with reservations]. F1000Research. 2023;11(1103):1103. doi:10.12688/f1000research.125159.2
   Google Scholar
• Harapan H, Anwar S, Yufika A, et al. Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic. Pathog Glob Health. 2022;116(4):236–243. doi:10.1080/20477724.2021.2011580
   PubMed Web of Science ®Google Scholar
• Razai MS, Osama T, McKechnie DGJ, Majeed A. Covid-19 vaccine hesitancy among ethnic minority groups. BMJ. 2021;372:n513. doi:10.1136/bmj.n513
   PubMed Web of Science ®Google Scholar
• Garcia LL, Yap JFC. The role of religiosity in COVID-19 vaccine hesitancy. J Public Health. 2021;43(3):e529–e30. doi:10.1093/pubmed/fdab192
   Google Scholar
• Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160. doi:10.3390/vaccines9020160
   PubMed Web of Science ®Google Scholar
• Vaccine apathy: status, challenges, and prospects; 2022. Available from: https://www.frontiersin.org/research-topics/41534/vaccine-apathy-status-challenges-and-prospects#overview. Accessed October 20, 2022.
   Google Scholar
• Barratt DJ, Beckett MR, Acton MM, Sebastian MS, Nguyen MW. Adult Vaccination in the Asia Pacific: mobilizing policy and practice knowledge; 2019. Available from: https://ifa.ngo/wp-content/uploads/2019/10/Adult-Vaccination-in-The-Asia-Pacific-%E2%80%93-Mobilizing-Policy-and-Practice-Knowledge.pdf. Accessed October 20, 2022.
   Google Scholar
• Matsui D, Shigeta M, Ozasa K, Kuriyama N, Watanabe I, Watanabe Y. Factors associated with influenza vaccination status of residents of a rural community in Japan. BMC Public Health. 2011;11(1):149. doi:10.1186/1471-2458-11-149
   PubMedGoogle Scholar
• Liu S, Xu E, Liu Y, et al. Factors associated with pneumococcal vaccination among an urban elderly population in China. Hum Vaccin Immunother. 2014;10(10):2994–2999. doi:10.4161/21645515.2014.972155
   PubMed Web of Science ®Google Scholar
• Jiang M, Li P, Yao X, et al. Preference of influenza vaccination among the elderly population in Shaanxi province, China. Hum Vaccin Immunother. 2021;17(9):3119–3125. doi:10.1080/21645515.2021.1913029
   PubMed Web of Science ®Google Scholar
• Melo A, de Macêdo LS, Invenção M, et al. Third-generation vaccines: features of nucleic acid vaccines and strategies to improve their efficiency. Genes. 2022;13(12):2287. doi:10.3390/genes13122287
   PubMed Web of Science ®Google Scholar
• Skibinski DA, Baudner BC, Singh M, O’Hagan DT. Combination vaccines. J Glob Infect Dis. 2011;3(1):63–72. doi:10.4103/0974-777X.77298
   PubMedGoogle Scholar
• Paguio JA, Yao JS, Dee EC. Silver lining of COVID-19: heightened global interest in pneumococcal and influenza vaccines, an infodemiology study. Vaccine. 2020;38(34):5430–5435. doi:10.1016/j.vaccine.2020.06.069
   PubMed Web of Science ®Google Scholar
• Gong L, Zhang X, Qu Z, et al. Public interest in distribution and determinants of influenza and pneumonia vaccination during the COVID-19 pandemic: an infodemiology and cross-sectional study from China. Vaccines. 2021;9:1329. doi:10.3390/vaccines9111329
   Web of Science ®Google Scholar
• Zhou M, Zhan J, Kong N, Campy KS, Chen Y. Factors associated with intention to uptake pneumococcal vaccines among Chinese elderly aged 60 years and older during the early stage of COVID-19 pandemic. Psychol Health Med. 2022;27(1):91–105. doi:10.1080/13548506.2021.1905862
   PubMed Web of Science ®Google Scholar
• Zaini K, Ha HT. Understanding the selective hesitancy towards Chinese vaccines in Southeast Asia; 2021. Available from: https://www.iseas.edu.sg/articles-commentaries/iseas-perspective/2021-115-understanding-The-selective-hesitancy-towards-chinese-vaccines-in-southeast-asia-by-khairulanwar-zaini-and-hoang-thi-ha/. Accessed October 20, 2022.
   Google Scholar
• Thanapluetiwong S, Chansirikarnjana S, Sriwannopas O, Assavapokee T, Ittasakul P. Factors associated with COVID-19 vaccine hesitancy in Thai seniors. Patient Prefer Adherence. 2021;15:2389–2403. doi:10.2147/PPA.S334757
   PubMed Web of Science ®Google Scholar
• Singapore’s older adults resist COVID-19 vaccinations; 2021. Available from: https://news.smu.edu.sg/news/2021/07/06/singapores-older-adults-resist-covid-19-vaccinations. Accessed October 20, 2022.
   Google Scholar
• Ang LW, Cutter J, James L, Goh KT. Factors associated with influenza vaccine uptake in older adults living in the community in Singapore. Epidemiol Infect. 2017;145(4):775–786. doi:10.1017/S0950268816002491
   PubMed Web of Science ®Google Scholar
• Moosa AS, Wee YMS, Jaw MH, et al. A multidisciplinary effort to increase COVID-19 vaccination among the older adults. Front Public Health. 2022;10:904161. doi:10.3389/fpubh.2022.904161
   PubMed Web of Science ®Google Scholar
• Tsai TF, Rao RD, Xu ZY. 75 - immunization in the Asia-Pacific region. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, editors. Plotkin’s Vaccines. Seventh ed. Elsevier; 2018:1466–85.e2.
   Google Scholar